Woodline Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-797,953
| Closed | -$4.14M | – | 1017 |
|
|
2024
Q3 | $4.14M | Buy |
+797,953
| New | +$4.14M | 0.03% | 406 |
|
|
2023
Q3 | – | Sell |
-107,580
| Closed | -$2.72M | – | 772 |
|
|
2023
Q2 | $2.72M | Buy |
+107,580
| New | +$2.72M | 0.03% | 386 |
|
|
2021
Q4 | – | Sell |
-175,359
| Closed | -$4.89M | – | 807 |
|
|
2021
Q3 | $4.89M | Buy |
+175,359
| New | +$4.89M | 0.08% | 253 |
|